Bartonella henselae: Etiology, Epidemiology, Pathogenesis, and Clinical Management in Cats
1. Introduction
Bartonella henselae is a fastidious, Gram-negative, facultative intracellular bacillus belonging to the order Rhizobiales within the class Alphaproteobacteria [1]. This organism is the primary etiologic agent of cat scratch disease (CSD), a zoonotic infection that typically manifests as a self-limiting regional lymphadenopathy in immunocompetent individuals [2, 3]. The domestic cat (Felis catus) serves as the principal reservoir host, and the bacterium is transmitted among cats and from cats to other mammals through the bite or scratch of an infected flea, Ctenocephalides felis [4, 5]. In feline medicine, B. henselae is recognized as an important pathogen associated with a spectrum of clinical presentations, including fever, lymphadenitis, endocarditis, and ocular disease, although many infected cats remain asymptomatic carriers [6, 7]. The organism has also been identified in dogs and in a variety of wild and domestic animal species, underscoring its broad host range [8]. The following reference article provides a detailed, evidence-based review of Bartonella henselae with a focus on veterinary medicine, microbiology, and molecular diagnostics, drawing exclusively on the peer-reviewed literature listed in the references section.
2. Etiology and Phylogenetic Characteristics
Bartonella henselae is a small (0.3–0.5 μm × 1.0–2.0 μm), curved, pleomorphic rod that is oxidase-negative and catalase-negative [1]. The bacterium is highly fastidious, requiring enriched media such as blood agar supplemented with 5% defibrinated sheep blood and incubation in 5% carbon dioxide at 35–37°C for 14–21 days for primary isolation [1, 7]. The complete genome of a feline-derived strain has been characterized, revealing genes encoding adhesins, type IV secretion systems, and immunomodulatory proteins that facilitate intracellular survival and endothelial cell binding [9]. Phylogenetic analyses place B. henselae within a clade that includes Bartonella clarridgeiae and Bartonella quintana, all of which share a common reliance on arthropod vectors for transmission [4, 10]. The genome size is approximately 1.9 Mbp with a G+C content of around 38.8 mol% [9]. Multilocus sequence typing distinguishes several genotypes, with genotype I (Houston-1) and genotype II (Marseille) being the most frequently isolated from cats and humans [5, 7].
3. Transmission and Vector Ecology
The primary biological vector for B. henselae is the cat flea (Ctenocephalides felis) [4, 11]. Fleas acquire the bacterium by feeding on bacteremic cats, and the organism replicates within the flea midgut and is excreted in flea feces [4]. Transmission to cats occurs through intradermal inoculation of contaminated flea feces via scratching or biting; direct flea bites are less efficient [4]. The bacterium has been detected in fleas collected from both dogs and cats in Portugal, indicating a high prevalence in flea populations in endemic regions [12]. Metagenomic studies of flea microbiomes have identified B. henselae as a dominant pathogenic species, often co-occurring with other vector-borne pathogens such as Anaplasma platys and hemoplasmas [12, 11]. In addition to the cat flea, molecular evidence has demonstrated B. henselae DNA in Rhodnius prolixus triatomine bugs and in Cairina moschata ducks used as blood meal sources in insectaries, suggesting that the bacterium may persist in non-traditional vectors and avian hosts under experimental conditions [13]. However, the epidemiological significance of these findings for feline infection remains to be fully elucidated.
Flea-infested environments, including homes and shelters, serve as reservoirs for infected fleas, and flea-borne transmission among cats is the primary mechanism maintaining the enzootic cycle [11]. Direct cat-to-cat transmission without fleas is considered negligible. B. henselae can also be transmitted iatrogenically via blood transfusions from infected donor cats [5]. The seroprevalence of B. henselae in cat populations varies widely by geographic region, with studies from Portugal reporting rates above 20% in healthy cats [5], while data from southern Brazil indicate that a substantial proportion of clinically healthy cats harbor both B. henselae and hemotropic mycoplasmas [6]. Risk factors for feline infection include outdoor access, multi-cat households, young age (< 3 years), and high flea burden [14, 5].
4. Pathogenesis and Host Cell Interactions
Bartonella henselae employs a multifaceted strategy to invade and persist within host cells. The bacterium preferentially adheres to and invades endothelial cells and erythrocytes, a property that is critical for establishing chronic bloodstream infection in the reservoir host [9, 7]. The complete genome analysis of a feline strain identified enhanced endothelial interaction phenotypes, including upregulation of adhesins that bind to vascular cell adhesion molecules [9]. Once internalized, B. henselae escapes from the endocytic vesicle into the cytoplasm, where it replicates and triggers the formation of a specialized intracellular niche [1]. The organism also invades feline erythrocytes, where it survives for the remainder of the erythrocyte lifespan, thereby enabling transmission to fleas during blood meals [4, 7].
The immunomodulatory capabilities of B. henselae are central to its pathogenic success. The bacterium suppresses the host innate immune response by down-regulating proinflammatory cytokine production and by subverting the activation of Toll-like receptor signaling pathways [9]. In experimentally infected cats, a longitudinal assessment of immune responses demonstrated that specific antibodies (IgG and IgM) appear within 2–4 weeks post-inoculation, but cellular immune responses are delayed and inconsistent, allowing persistent bacteremia to develop in the majority of cats [7]. The bacterium also induces vasculoproliferative lesions, particularly in immunocompromised hosts, by secreting angiogenic factors such as vascular endothelial growth factor (VEGF) [1]. This angioproliferative phenotype is responsible for the characteristic granulomatous lesions seen in cat scratch disease and for the rare but severe manifestations of bacillary angiomatosis in immunocompromised animals [15, 1].
5. Clinical Manifestations in Cats
Many cats infected with B. henselae remain clinically healthy, serving as asymptomatic carriers with intermittent bacteremia lasting months to years [6, 7]. When clinical signs occur, they are often non-specific and may include fever of unknown origin, lethargy, lymphadenopathy, gingivitis, and ocular disease such as uveitis or neuroretinitis [16, 17, 18]. A study on experimentally infected cats documented that some individuals develop transient fever and mild lymphadenomegaly, while others show no outward signs despite sustained bacteremia [7]. The relationship between B. henselae infection and feline uveitis has been investigated; the bacterium is considered a potential cause of anterior uveitis, especially in cats with concurrent flea infestation [19, 18]. Endocarditis is a less common but severe manifestation of bartonellosis in cats, typically affecting the aortic or mitral valves and often accompanied by thrombo-inflammatory changes [15, 20].
In dogs, B. henselae infection has been documented primarily as a co-infection in animals with clinical suspicion of visceral leishmaniasis, with molecular detection by PCR from blood and tissue samples [8]. Canine bartonellosis can present with endocarditis, lymphadenitis, and granulomatous hepatitis, but the full clinical spectrum in this species is still being characterized [8]. In South America, B. henselae has been detected in dogs in regions where feline flea populations are high, suggesting potential spillover from the feline reservoir [8].
6. Diagnostic Approaches
Diagnosis of Bartonella henselae infection in cats relies on a combination of serological, molecular, and culture-based methods. Serological testing using indirect immunofluorescence assays (IFA) or enzyme-linked immunosorbent assays (ELISA) detects anti-B. henselae IgG and IgM antibodies [14, 7]. However, serology cannot distinguish active from past infection, and seroprevalence in healthy cat populations is high in endemic areas [14, 5]. Polymerase chain reaction (PCR) targeting the 16S–23S rRNA intergenic spacer region or the gltA gene is the preferred molecular diagnostic tool due to its sensitivity and specificity [12, 5, 8, 21]. A PCR-confirmed case of femoral lymph node abscess in a cat demonstrated the utility of this method when serological and culture results are inconclusive [21].
Metagenomic next-generation sequencing (mNGS) has emerged as a powerful diagnostic modality for detecting B. henselae in tissues and body fluids, particularly in atypical or severe cases where conventional PCR panels fail [22, 23]. In a retrospective analysis of pediatric CSD cases, mNGS confirmed B. henselae infection in 87% of cases, outperforming serology alone [23]. This technology is increasingly applied in veterinary diagnostic laboratories for the detection of fastidious or unexpected pathogens.
Culture of B. henselae from blood, lymph nodes, or other tissues remains the gold standard for definitive diagnosis but is rarely performed in clinical veterinary practice due to the long incubation period (up to 21 days) and the need for specialized media [1, 7]. Automated impedance analyzers and chromatographic methods are not applicable to Bartonella culture due to the bacterium's slow growth.
There is ongoing research into the relationship between feline AB blood type and susceptibility to Bartonella species infection. A recent study found no evidence that cats with phenotype-B blood differ in susceptibility or resistance to B. henselae compared to phenotype-A cats, indicating that blood type is not a significant risk factor for feline bartonellosis [24].
graph TD
A[Cat with suspected bartonellosis], > B{History of flea exposure?};
B, >|Yes| C[Perform serology (IFA/ELISA)];
B, >|No/Unclear| C;
C, > D{Seropositive?};
D, >|Yes| E[Confirm with PCR (blood or tissue)];
D, >|No but high suspicion| F[Consider PCR or mNGS];
E, > G{PCR positive?};
G, >|Yes| H[Diagnosis: active infection];
G, >|No| I[Consider mNGS or culture];
F, > J{mNGS/culture positive?};
J, >|Yes| H;
J, >|No| K[Likely not B. henselae; explore other etiologies];
H, > L[Initiate antimicrobial therapy if clinical signs present];
Figure 1. Diagnostic decision tree for suspected Bartonella henselae infection in cats.
7. Treatment and Antimicrobial Susceptibility
While B. henselae is susceptible to several antimicrobial classes in vitro, including macrolides, rifamycins, fluoroquinolones, and tetracyclines, treatment of infected cats remains controversial because most cases are self-limiting or chronic [25, 21]. In cats with confirmed clinical bartonellosis (e.g., uveitis, endocarditis, lymphadenitis), antimicrobial therapy is indicated. Combination antibiotic therapy is often required to eliminate B. henselae from multiple microenvironments, including intracellular and biofilm-associated niches [25]. A recent in vitro study demonstrated that monotherapy with doxycycline or azithromycin is insufficient to clear the bacterium from endothelial cells, whereas a combination of azithromycin plus rifampin achieved sterilization of the intracellular compartment [25]. These findings align with clinical reports of rifabutin-based regimens used for ocular bartonellosis, although corneal deposits have been noted as a side effect of rifabutin therapy [26].
For focal infections such as lymph node abscesses, surgical drainage combined with antimicrobial therapy (typically a macrolide or tetracycline for 2–4 weeks) is recommended [21]. In cases of treatment-resistant abscesses, PCR confirmation is essential to rule out other causative agents and to guide appropriate therapy [21]. The optimal duration of therapy for systemic infections has not been established, but a period of 4–6 weeks is commonly employed based on case series [25, 15].
8. Prevention and Control
Prevention of B. henselae infection in cats rests on rigorous flea control [4, 11]. Regular application of adulticide flea products to all cats in the household, coupled with environmental flea management, reduces the risk of flea-borne transmission [11]. Because fleas can remain infective in the environment for weeks, integrated pest management is recommended [4]. Cats should be kept indoors to minimize exposure to flea-infested environments and to wildlife that may carry fleas [5]. For cats used as blood donors, screening for B. henselae via PCR is advisable, given the bacterium's ability to survive in stored blood [5]. There is currently no licensed vaccine for B. henselae in cats, although in silico design of a cross-protective multi-epitope vaccine against B. henselae and B. clarridgeiae has been reported [10]. This computational approach identified candidate epitopes from cell surface proteins that could potentially elicit humoral and cellular immune responses; however, experimental validation in animal models has not yet been completed [10].
9. Frequently Asked Questions
What is the primary reservoir host for Bartonella henselae?
The domestic cat (Felis catus) serves as the principal reservoir host, in which the bacterium establishes a chronic, often asymptomatic bacteremia [1, 5].
How is Bartonella henselae transmitted among cats?
The cat flea (Ctenocephalides felis) is the primary vector. Transmission occurs through intradermal inoculation of flea feces into scratch wounds or bite sites [4, 11].
What are the most common clinical signs of bartonellosis in cats?
Most infected cats show no clinical signs. When present, findings include fever, lethargy, lymphadenopathy, gingivitis, uveitis, and rarely endocarditis [6, 7, 20].
Which diagnostic method is preferred for confirming active infection in cats?
Polymerase chain reaction (PCR) targeting the 16S–23S rRNA intergenic spacer or gltA gene is the preferred method for confirming active infection [22, 5, 21]. Metagenomic next-generation sequencing (mNGS) is a more sensitive alternative for atypical cases [22, 23].
Is antibiotic therapy always required for Bartonella-infected cats?
Antibiotic therapy is indicated only for cats with clinical disease (e.g., uveitis, lymphadenitis, endocarditis). Asymptomatic bacteremic cats generally do not require treatment [25, 7].
What antimicrobial combination has been shown to be effective for intracellular clearance?
Combination therapy with azithromycin and rifampin has demonstrated superior efficacy in eliminating B. henselae from endothelial cell cultures compared to monotherapy [25].
Can Bartonella henselae be transmitted via blood transfusion in cats?
Yes, B. henselae can survive in stored blood, making transfusion a potential iatrogenic transmission route [5]. Screening feline blood donors by PCR is recommended.
Does feline AB blood type affect susceptibility to Bartonella infection?
Current evidence indicates that phenotype-B blood type does not confer increased susceptibility or resistance to B. henselae infection in cats [24].
10. Conclusion
Bartonella henselae remains an important pathogen in feline medicine due to its high prevalence in cat populations, its flea-borne transmission, and its potential to cause both asymptomatic carrier states and clinically significant disease. The fastidious nature of the bacterium demands specialized diagnostic approaches, with molecular methods such as PCR and mNGS providing the highest sensitivity for detection. Antimicrobial therapy, when indicated, should employ combination regimens to ensure intracellular clearance. Flea control is the cornerstone of prevention. Ongoing genomic and immunoproteomic studies continue to refine our understanding of host-pathogen interactions and hold promise for future vaccine development.
References
[1] Stephen T, Vijayan V. Bartonellosis. PubMed. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/28613624/
[2] Bonilla P, Pulido K, Bell N, et al. Atypical Presentation of Pediatric Cat Scratch Disease: A Case Report. Cureus. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42371469/
[3] Yakubovsky M, Katzir M, Atamna A, et al. Cat-Scratch Disease Associated with Acute Hearing Loss, Israel. Emerg Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42366106/
[4] Brown LD. From Acquisition to Transmission: Revisiting Bartonella henselae Infection in the Cat Flea (Ctenocephalides felis). Vector Borne Zoonotic Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41860756/
[5] Lopes R, Carvalho HL, Sampaio F, et al. Molecular Detection of Bartonella henselae in Healthy Cats from Portugal (2015-2025): One Health Context and Implications for Transfusion Medicine. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754384/
[6] Dallmann PRJ, Lima DD, Silveira CX, et al. First report of multiple infection by Anaplasma platys, Bartonella henselae, and hemoplasmas in clinically healthy domestic cats from Southern Brazil. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41831185/
[7] Shamsul-Bahri NA, Omar S, Watanabe M, et al. Longitudinal assessment of immune responses against Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41643374/
[8] Miranda VD, Dos Santos LS, Torres MM, et al. Molecular identification of Bartonella henselae in dogs with clinical suspicion of visceral leishmaniasis. Rev Inst Med Trop Sao Paulo. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41711927/
[9] Cai Y, Yuan G, Wang C. Complete genome and phenotypic characterization of a feline-derived Bartonella henselae strain with enhanced endothelial interaction and immunomodulatory phenotypes. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42335804/
[10] Şeflekçi Y, Köseoğlu AE, Erdoğdu Sever R, et al. Design and computational evaluation of a cross-protective multi-epitope vaccine candidate against Bartonella henselae and Bartonella clarridgeiae pathogens causing the zoonotic cat scratch disease in humans. Comput Biol Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41619363/
[11] Gin TE, Moore CO, Tomlinson T, et al. Pathogenic bacterial species and the microbiome of cat fleas (Ctenocephalides felis) inhabiting flea-infested homes. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41615983/
[12] Pereira A, Cruz A, Cruz J, et al. Molecular detection of zoonotic pathogens in fleas collected from dogs and cats in Portugal. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42218469/
[13] Santos LSD, Velho PENF, Oliveira J, et al. Between insects and birds: molecular evidence of Bartonella henselae DNA in Rhodnius prolixus (Stål, 1859) from an insectary and Cairina moschata (Linnaeus, 1758) ducks used as triatomine blood meal source. Rev Inst Med Trop Sao Paulo. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307305/
[14] Lee A, Kim U, Baik SY, et al. Seroprevalence of Bartonella henselae Immunoglobulin G and Associated Risk Factors Among Adults Undergoing Health Screening in Urban Korea. Zoonoses Public Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41845555/
[15] Gobbo G, Zacchia M, Nalesso F, et al. Bartonella henselae infection associated with a multisystemic thrombo-inflammatory syndrome in an immunocompetent adult. Infection. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41986819/
[16] Koga S, Iida K, Onouchi H, et al. Severe Optic Neuroretinitis and Vitreous Hemorrhage in Pediatric Cat-Scratch Disease: A Case With Irreversible Visual Impairment. Am J Case Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42013046/
[17] Ucan Gunduz G, Akalin H, Yalcinbayir O. Bilateral diffuse retinal vasculitis secondary to Bartonella henselae infection. J Fr Ophtalmol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41862392/
[18] Hassan KM, Ihbibane F, Otsasso M, et al. Atypical ocular bartonellosis: A case report. IJID Reg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41586032/
[19] Hazidi SCM, Rosli AH, Jabbari AJ. Severe panuveitis - Uncommon presentation of cat scratch disease. Oman J Ophthalmol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41929998/
[20] Wohlgenant Z, Hansen M, McDonough M, et al. Bartonella henselae tricuspid valve endocarditis presenting as fever of unknown origin. BMJ Case Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41638765/
[21] Inoue S, Sumii S, Araki K, et al. Treatment-Resistant Femoral Lymph Node Abscess Caused by Cat Scratch Disease: A Case Confirmed by Polymerase Chain Reaction. Cureus. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41583232/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[22] Yue Y, Kang YJ, Wang H, et al. Diagnosis of Cat-Scratch Disease by Metagenomic Next-Generation Sequencing. Vector Borne Zoonotic Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41915541/
[23] Lai SY, Chang L, Duan JX, et al. Clinical and epidemiological characteristics of cat scratch disease in children from southwestern China: a retrospective analysis of mNGS-confirmed cases. Front Public Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41641055/
[24] Spada E, Proverbio D, Perego R, et al. Susceptibility or resistance to Bartonella spp. infection in cats: Does the phenotype-B blood matter? Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42250567/
[25] Olsen EL, Embers ME. Combination antibiotic therapy is required to eliminate Bartonella henselae in multiple microenvironments. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42005843/
[26] Song A, Daluvoy MB, Cummings TJ. Visually significant corneal deposits associated with rifabutin therapy for Bartonella henselae. Am J Ophthalmol Case Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42064646/
[27] Pierson S, Chabannes M, Lang S, et al. Case Report: Successful treatment of Bartonella henselae-associated crescentic glomerulonephritis in renal transplant recipient. Front Med (Lausanne). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42292227/
[28] Yow BLH, Kittaka RC, Yeung CSJ. Discordant ANCA Positivity in Immune Complex Glomerulonephritis Secondary to Bartonella henselae Prosthetic Valve Endocarditis. Nephrology (Carlton). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42168832/
[29] DU WQ, Liu LJ, Zhang L, et al. [A case of Bartonella henselae meningitis characterized by bone marrow hemophagocytosis]. Zhongguo Dang Dai Er Ke Za Zhi. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42130363/
[30] Arabeyre C, Lheritier S, Rached A, et al. Peripheral neurological involvement due to Bartonella henselae in an immunocompetent adolescent: a case report and literature review. Diagn Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42127721/
[31] Peng Y, Wang L, Zhou B, et al. Self-limiting isolated choroidal granuloma with serous retinal detachment: atypical cat scratch disease without feline exposure. BMC Ophthalmol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41882600/
[32] Dong Y, Alhaskawi A, Zou X, et al. Retraction Note: Post-COVID reactivation of latent Bartonella henselae infection: a case report and literature review. BMC Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41803837/
[33] Illiano W, Crosson J. A typical Vitelliform-Like Maculopathy Secondary to Bartonella henselae Neuroretinitis. J Vitreoretin Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41727755/
[34] Debyser T, Falter M, Vanhoutte T, et al. Disseminated Bartonellosis Masquerading as Autoimmune Glomerulonephritis: A Case Report. Case Rep Nephrol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41684369/
[35] Luna JC, Shaffer RW. Sonographic Evaluation of an Inguinal Bubo from Bartonella henselae: A Case Report. Clin Pract Cases Emerg Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41666881/